Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Guest columnist article from Mitch:
https://www.richmondregister.com/opinion/columns/mcconnell-kentucky-leads-with-industrial-hemp/article_6d324671-a41f-5902-8851-0a2cc9e89cec.html
Nothing really new on the news front, but he does point out the meeting he had with the FDA and need for large finance to support the industry.
I think that is a sound prediction for Q2 revenue.
What I find interesting is if revenue amounts to $311k, then the gross margin will be $236k if it remains at 76%
Kona’s Q2 reported $730k, but at a 30.5% gross margin. Their gross income was $223k. So, Vate’s will likely be higher, yet Kona valued at $90 mil and Vate is $17.5 mil.
Looking forward to Vate closing that gap.
I just reviewed the 10-Q for FRTN.
It was really easy to see that FRTN has:
No growth
Been taking on an obscene amount of debt
went from positive net income to a massive loss within a year
numerous lawsuits for debt repayment
no news for shareholders
How can anyone read that financial statement, and think this is a great investment? Or for that matter, think it's worth investing even a dollar?
You are breaking every rule of sensible investing if you buy into this mess.
Also, this private placement quickly gained over 20% from .029 for a $800k+ gain. Even better, it exists as only a paper gain for six months, as these shares won't even see the market near term.
Then you wake up, and come to the realization that there is nobody in the world who wants in on this thing.
Number of shares traded today = 0
Number of people that will want to buy shares of FRTN tomorrow = 0
Amount of money you will make buying 1,000 shares of FRTN = $0
Amount of money you will make buying 10,000 shares of FRTN = still $0
Likelihood that more than one person will ever be interested in FRTN = 0%
Here is the FRTN volume for last week:
Aug 09 2019 0
Aug 08 2019 2,800
Aug 07 2019 0
Aug 06 2019 0
Aug 05 2019 0
Most likely, that 2,800 was someone selling it to themselves. Or, perhaps they were trying to buy FRT (Federal Reality Investment Trust) and due to a typo accidently bought FRTN. Sometimes that happens.
No, Vate still looks good and is quite legitimate.
I FORcast aTRANs as being the true scam out there. Too bad there is no one even interested in participating in that mess.
Actually, that is good news. It means they had Vate coffee in stock and Consumers are buying it out.
Yesterday I was in my local store hoping to pickup a box of Count Chocula and they were out. Some store clerk didn’t know when they would get their next order in either. Guess that also means General Mills is having troubles.
THe DJIA is getting hammered today, so CANB down less than 1% is actually a pretty good day so far.
That concentration sounds possible also. This could create the potential for the public cbd bev companies to have some of their product pulled from the shelves, or at least be at risk for it. Vate would be free and clear, since I don't see 10 Mg per 12 oz being an issue.
In that circumstance, what investor would want take on that risk? Vate would have additional exclusivity in the entire CBD bev space besides being the only public RTD iced coffee and tea.
Actually Sleek, it’s my money that is smart for being invested in Vate and Canb. Me personally, not that smart. Money be smart.
Besides THC free isolates being a requirement of enforcement discretion, I wonder if concentration will also play a major factor in excluding certain lines of RTD's?
"we will give you some cutoffs for purity, potency and concentration of CBD that we think are safe even though we don’t have any conclusive data to guarantee safety until the food industry does the research."
VATE's RTD coffee has 10 Mg CBD for a 12 oz can
VATE's RTD iced tea has 10 Mg CBD for a 16.9 oz bottle
Other RTD's, for example, have the following:
NBEV's Marley CBD infused has 25 Mg CBD for a 15.5 oz can
Sprig soda has 20 Mg CBD for a 12 oz can
PURA's CBD infused water line has 10 Mg and 25 Mg per 16.9 oz bottle
Kickback Cold brew coffee with CBD has 20 Mg per 11 oz bottle
So, although the FDA will allow it in RTD's, they will be conservative and want to keep the concentration lower at the outset. I am thinking a ratio of 1 Mg CBD to 1 oz liquid may be the max cutoff. That would allow both of Vate's RTD's to be legal. Products that are higher, like Marley, Kickback and PURA's 25 Mg CBD would then be deemed in violation of the FDA guidelines.
Plus add the total denial that took place when SPCL was delisted. Holding false hope, and proclaiming that they wanted to go private, and that it was a good thing for shareholders. Reality then set in that shares are worth nothing.
What is also totally believable is someone who claims to have a tally of over a million shares, a majority of them free, who day in and day our roots for the stock to go down in flames. Essentially, making the “free” shares that they have accumulated worthless. Yea, makes sense to me and is totally believable.
Enjoying the laughs too.
Again, where is it expressed as a label problem in the press release? Here is the exact excerpt, again: "We are currently making some enhancements to our labels"
I agree that the amount of info leaves a lot to be desired. However, there is a big difference between "enhancements" and "problem. KG, for example, had cans with wrapped labels. They made an enhancement to switch to printed cans. In Vate's case, they are changing the label, which they feel will be positive. Therefore, it's an enhancement and not a problem. Something like a label misprint or lawsuit due to copyright issue would constitute a "problem"
Not disagreeing that we deserve more info, but with the little info we get it's important to maintain accuracy. I am not totally comfortable with partial transparency, but it's nothing new. And the progress has been positive so far this year, so I am inclined to give Vate some leeway for now.
Here is the exact quote from the press release: "We are currently making some enhancements to our labels while we calculate a much larger reorder to keep up with the demand for our CBD ready to drink beverages.”
Where did you come up with production problems due to labeling from that statement?
I am pretty happy with $65k over half a quarter.
Multiply that by 2, and you have $130k for a full quarter, or over half a million annually.
Q1 2019 revenue was $166k on hemp products, RTD was not in play yet. Across four quarters, we have $664k. Add that to the RTD revenue, and you have almost $1.2 million. That is the absolute minimum we will see at the end of the year. However, it's not factoring in revenue growth from:
* 93% revenue growth in brick and mortar stores
* Increase in Amazon sales to $20k per month
* Now 16 distributors in 12 states. (KG plans on distributors in all 50 states by EOY. Vate can accomplish that also in first half 2020
* $65k was the first 45 days, and only going up from there
Other factors we can't lose sight of:
* Vate eliminated all convertible notes, very little debt
KG took a nice leg up at the end of April, and held above .105. If Vate is trailing KG by six months, then we are looking at end of Oct / early Nov when Q3 comes out for a huge rise, if not sooner. Combine that with the CBD guidance from FDA in next couple of months, and there is a tremendous amount of fuel building up.
Back in June I did a very high level comparison of Canb and CBD Unlimited. At the time Canb looked similar in revenue, with more assets and less debt. Now I believe Canb will leave CBD Unlimited in the dust.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149277862
Today's volume is nearing the entire volume for last week (2.5 mil). Also, the most volume in over a month. Only being down slightly with a significant spike in volume looks positive.
Your talking to the same person that called Vate’s Sister company KG a “scam” while posting a while back. Therefore, anyone who listened to that advice got “scammed” out of huge investment gains.
Florida looking to replace dying citrus groves with hemp:
https://www.washingtonpost.com/national/a-state-long-linked-to-oranges-looks-to-a-lucrative-future--with-hemp/2019/07/07/de195aac-9f71-11e9-9ed4-c9089972ad5a_story.html
Interesting that they appointed a “Director of Cannabis”
The cash on the Canb Q1 2019 is $567,291. Not sure why a half million dollars is considered "no cash"
The balance sheet from Canb's Q1 2019 states:
Property and equipment, at cost less accumulated depreciation of $34,738 and $20,248, respectively
Amount: $743,368
You are probably referring to the 10k, when it was $59,619. The Quarterly filings have more current information than the annuals.
So, KG’s hi/low spread was 7.8% today. Let me guess, you managed to somehow flip it for a 10% gain today? Outstanding!
Ready for tomorrow’s tall tale
Why don’t you get 143,350 shares instead of 84,900? This way you can tell people that you own half a million Vate shares versus an off number such as 441,500. Half million always sounds more impressive than 400 thousand something.
Also, you should slap the ask with your 143,350 buy. It will cost you a few hundred more, but it could be the first buy of the Vate breakout.
The handle is still forming, so you are incorrect to say that it’s failed. The height of the right side of the cup occurred at close on 5/28 at .051. In the past month, it retraced 16%, which is bullish since it typically can be over 30%.
You are aware that a handle typically forms over the course of 1 to 6 weeks, right? Given it’s only been four weeks, the cup and handle is still alive and well, ready for the imminent breakout .
The share count for Vate posted on June 7th (which covers the month of May) showed that there was an increase of zero shares. During that month, there were six posts claiming that Vate was diluting which were not correct.
What should make us think that this latest claim of dilution is true?
Things should be going well given that Duramed is hiring for a medical biller for the corporate office.
I like the job line subject: "Medical Company Seeking Data Entry/Clerical help with endless growth potential"
https://www.indeed.com/jobs?q=Medical%20Coding&l=Long%20Island%2C%20NY&advn=9479733648568174&vjk=bf78d3868da12c12&apply=1
Essentially it's the same spiel over and over and over again. Like a broken record. I find it humorous how hard it tries to impress everyone.
Just a wannabe trader with a track record of pumping a de-listed company that ripped off their investors, and a couple of others that tanked or did nothing.
I’ll add another:
18) VATE is on a parallel growth trajectory as KG, and only trails them by about six months. KG currently sits at $83 million market cap, and was recently over $100 million cap before a normal pullback after a sharp jump. VATE is at $23 million market cap. VATE has the potential to at least triple or quadruple its market cap in a very short period of time if it continues that trajectory, and so far they are demonstrating that it’s highly likely.
Actually, I think this post is great news.
Because: when the only negative arguments against Canb revolve around ridiculous things such as their NY accents, non-existent mold concerns, not having gummy bears (that no one cares about) and reverse splits for uplisting to a premier exchange, then things are looking really great for Canb.
What new investor is going to come along, see that Canb does not have gummy bears, and move on without investing?
OR,
What new investor is going to come along and assess Canb's efforts to uplist to Nasdaq, and say "Naw, I'll pass. There are no quality companies on the Nasdaq. Not compared to the quality found on the OTC"
There is a noticeable difference this time. Going back to the chart, every time Vate peaked high in the past it then sharply sold off. The past trend was typically a loss of 30%+ within 13 trading days.
However this time, it dipped and held. The past 13 trading days, Vate is within 11% of its recent high closing price of .051 on 5/28. This behavior is significantly different, in a bullish way.
No, I didn't see anything regarding exclusivity, and CVSI only mentioned its CBD roll on, but not any other of its products as part of the deal. The CEO for CVSI is releasing more details tomorrow.
Kroger's posted announcement indicated they will carry, "topical products like lotions, balms, oils and creams", so it certainly appears that other vendors would be included.
CV Sciences will be the distributor of Kroger's CBD products
https://www.otcmarkets.com/stock/CVSI/news/CV-Sciences-Inc-Announces-New-Distribution-With-Kroger-and-Expands-Its-Offering-of-Topical-Products?id=231370
Like shortorlong, I also disagree. Another aspect where Canb needs to consider share price is their agreements with outside companies and service providers. The asset purchase with Seven Chakras (1 mil shares) and Shi Farms $500k in shares (should be roughly 10 - 15 mil shares) are examples. These are shares that become a significant asset to those other companies and service providers. If they decide to hold, then they would also want the share price to increase significantly like we do. Canb won't want to compromise the integrity of those deals, which in turn would jeopardize future deals.
Outstanding shares updated on OTC Markets to 6/7/19 and shows VATE is still a hair under 500 Mil. So, it appears there was no dilution, if any.
The "authorized" shares are increasing to 1,500,000,000. Not the actual shares. That remains at 553 Million, although not updated yet for June.
The 8-k news will make the Shareholder meeting even more interesting....
Vate officially launched their CBD beverages on 4/29 when the stock opened at .0304. Currently, Vate is at .0455 which is a 50 % increase in share price since launch. I think you got mixed up, and meant to say the "gains"
are astounding instead of losses.
Most represented here are investors in KG, and some will take a percentage (smaller than their core investment) to create profit or increase share count.
Real traders that are experienced in the art of increasing their share count six fold, along with 100k in a few days, are not here posting on the Kona board. It's easy for anyone to make grandiose claims, since there is no proof of said accomplishments that needs to be provided.
My favorite line in the shareholder meeting press release:
"This is an informational meeting to update the shareholders of recent actions and future plans." Looking forward to hearing about the growth of DuraMed, and re-launch of Pure Leaf.
Alternatives to opioids is a hot topic with the FDA, Doctors and insurance companies. The SAM units w/CBD pads meet that criteria as an alternative treatment. Insurance companies recognize that its more cost effective to support (and reimburse) use of the units, versus treating an opioid addiction. Canb is well positioned to meet that need, and I think we will be pleasantly surprised with the demand.
I'll go with the former. Investors will jump in and Canb will then be valued as the speculative growth opportunity it should be. I think it will gain sharply, then give back some but settle at a much higher low.
Canb has been compared to CBD Unlimited a while back. Looking at current numbers (rounded - from latest 10-Q), tells the story that Canb is drastically undervalued:
CBD Unlimited
Q1 2019 Revenue: $681k
Cash: $54k
Assets: $2.1 Million
Liabilities: $3.6 Million ($2.5 Million is payable notes)
Market Cap: $109 Million (reached $212 Million in April)
Canbiola
Q1 2019 Revenue: $517k
Cash: $567k
Assets: $4.5 Million
Liabilities: $348k ($17k is payable notes)
Market Cap: $23 Million
Based on this comparison, Canb should be currently trading between $.20 pps (current value of EDXC) and $.40 pps (peak of EDXC). Not $.042
Check out their home page also - “something great is coming”
https://tridentdistributors.com